Comparison of Percutaneous Coronary Intervention Versus Conservative Treatment in Unstable Angina Pectoris
胡春燕,吕蓓,沈卫峰,陆国平
DOI: https://doi.org/10.3969/j.issn.1008-794x.2002.05.006
2002-01-01
Abstract:Objective To evaluate the efficacies of percutaneous coronary intervention (PCI) and drug treatment in patients with unstable angina (UAP). Methods 248 patients with UAP were divided into two groups: conservative group of 123 patients who received antiplatelet, anticoagulant and antianginal therapies only and invasive group of 125 patients who underwent additional PCI 4.4 days after admission, The ocurrence of death, AMI, recurrent angina, readmission were assessed during the first hospitilization year. Results There was no difference in the incidence of composite endpoint of death or AMI between the two groups during the hospitalization (0.8% vs 1.6%, P 0.05), but hospitalization duration was shorter in the invasive group than in the conservative group (10.3±5.6 days vs 14.6±10.7 days, P 0.01). In duration of one year, the incidence of AMI (2.4% vs 8.9%, P 0.03),death (1.6% vs 6.5%, P 0.05), composite endpoint of death or AMI (4.0% vs 13.0% P =0.02), recurrent angina pectoris (26.4% vs 48.7 P 0.001), CABG(1.6% vs 10.5%, P 0.01) and readmission (24.8% vs 45.5%, P 0.01) were also lower in the invasive group than in the conservative group. Survival rate free of composite death or AMI for 1 year was higher in the invasive group than in the conservative group(96.0% vs 86.9%, P 0.02). There was a definite benefit of the invasive treatment in reducing the risk of composite endpoint of death or AMI in patients with chest pain at rest, troponin T positive and three vessel diseases. Old age, three vessel diseases, LAD disease, lower LVEF, ST segment depression, diabetes and hypertension were the independent factors associated with composite of death or AMI. Conclusions In patients with UAP, PCI associated with routine antiplatelet, anticoagulant and antiischemic treatment significantly decreases the incidence of adverse cardiac events and improves the survival rate in one year. Such beneficial effects can be more obvious for high risk patients.